Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dalrymple, Dana G. 2012, Artemisia annua, Artemisinin, ACTs & Malaria Control in Africa: Tradition, Science and Public Policy , Washington DC: Politics & Prose Bookstore. Pp. 254. $18.00 ISBN: 978-0-615-61599-8

Dalrymple, Dana G. 2012, Artemisia annua, Artemisinin, ACTs & Malaria Control in Africa:... Malaria is one of the most debilitating diseases occurring in tropical and subtropical countries. It affects many millions of people throughout the world and kills at least one million children a year in Africa alone. Its eradication, or at least its control, has been the aim of world health authorities for many decades but without conspicuous success. At one time there existed the almost perfect drug for the treatment of malaria: chloroquine. It was developed by the Americans during the war against Japan and was cheap to produce, highly effective, and had few adverse side effects. Most importantly, it was effective against the most deadly form of malaria: falciparum malaria. During the 1970s it became apparent that chloroquine had lost its curative power. The malarial parasite had mutated and could now resist the toxic effect of chloroquine. For the Chinese army, fighting a war in the jungles of Vietnam where more fatalities could result from malaria than from combat, this was a disastrous development. In 1967 the Chinese government took decisive action and established Project 523, a large team of scientists from many scientific disciplines, to seek a new drug for the treatment of malaria. By the early http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Asian Medicine Brill

Dalrymple, Dana G. 2012, Artemisia annua, Artemisinin, ACTs & Malaria Control in Africa: Tradition, Science and Public Policy , Washington DC: Politics & Prose Bookstore. Pp. 254. $18.00 ISBN: 978-0-615-61599-8

Asian Medicine , Volume 7 (2): 482 – Jan 20, 2012

Loading next page...
 
/lp/brill/dalrymple-dana-g-2012-artemisia-annua-artemisinin-acts-malaria-control-TKnzfXzt9W

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Brill
Copyright
© Koninklijke Brill NV, Leiden, The Netherlands
Subject
Reviews
ISSN
1573-420X
eISSN
1573-4218
DOI
10.1163/15734218-12341265
Publisher site
See Article on Publisher Site

Abstract

Malaria is one of the most debilitating diseases occurring in tropical and subtropical countries. It affects many millions of people throughout the world and kills at least one million children a year in Africa alone. Its eradication, or at least its control, has been the aim of world health authorities for many decades but without conspicuous success. At one time there existed the almost perfect drug for the treatment of malaria: chloroquine. It was developed by the Americans during the war against Japan and was cheap to produce, highly effective, and had few adverse side effects. Most importantly, it was effective against the most deadly form of malaria: falciparum malaria. During the 1970s it became apparent that chloroquine had lost its curative power. The malarial parasite had mutated and could now resist the toxic effect of chloroquine. For the Chinese army, fighting a war in the jungles of Vietnam where more fatalities could result from malaria than from combat, this was a disastrous development. In 1967 the Chinese government took decisive action and established Project 523, a large team of scientists from many scientific disciplines, to seek a new drug for the treatment of malaria. By the early

Journal

Asian MedicineBrill

Published: Jan 20, 2012

There are no references for this article.